about
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewManagement of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature.A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.Analysis of safety from a human clinical trial with pterostilbene.Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview.Kidney function and estimated vascular risk in patients with primary dyslipidemiaFenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.Fenofibrate and the kidney: an overview.Summarizing the FIELD study: lessons from a 'negative' trial.Safety considerations with fenofibrate/simvastatin combination.Micronized fenofibrate: a useful choice for the correction of dyslipidemia in metabolic syndrome and Type 2 diabetes.Fibrate-induced increase in serum urea and creatinine levels.Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease.Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
P2860
Q28220294-83F1DBA8-1F1D-4E01-A3A5-35192DBA6798Q34068746-79E03D1C-D4B4-46E8-B623-44A399F6DB6BQ35569823-E0CB09F0-FA28-46D8-A3ED-37680607B754Q36011053-CA9ABC47-02B2-4AD0-8A0B-2528F9086BABQ36619155-BB64EAD2-4920-46B6-848B-0FF7D4A8FE8DQ36653658-AC9B7182-6DAA-4FA0-BD1A-DC47549BDC70Q37245464-AAF886ED-F5A4-4037-9CBD-8029FA6B83B5Q37898699-DE09A658-F423-4CE1-9ED9-D95F37AA981FQ38088377-C7E5A2C3-3377-420C-A1E1-078958BB617AQ38160901-A1577319-53C6-4B9D-8B4F-6E62DC02C33AQ38541832-ED47FC69-AD75-4B3A-A73D-10FD16A86FD7Q40274682-2EF92D2F-979F-411B-A7A3-A431E1C2F3CDQ43935636-CD8EA1F8-39D8-4601-90EE-D9A54BEB079DQ44258250-971F124C-F6EE-48D3-947C-A6D3BED546CCQ44571944-1FD90946-71B8-457D-8094-E56DA1C094B6
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Fibrate treatment can increase serum creatinine levels.
@en
Fibrate treatment can increase serum creatinine levels.
@nl
type
label
Fibrate treatment can increase serum creatinine levels.
@en
Fibrate treatment can increase serum creatinine levels.
@nl
prefLabel
Fibrate treatment can increase serum creatinine levels.
@en
Fibrate treatment can increase serum creatinine levels.
@nl
P2093
P2860
P356
P1476
Fibrate treatment can increase serum creatinine levels.
@en
P2093
Kakafika A
Tsimihodimos V
P2860
P356
10.1093/NDT/16.6.1301
P407
P577
2001-06-01T00:00:00Z